Patent term extensions are the most important instrument for securing rights to innovative medicines after expiry of the regular patent term. The new manual comments on all relevant provisions including the relevant case law in the U.S., Japan andEurope. In addition, it presents corresponding extension opportunities in Australia, Israel, Korea, Russia, Switzerland, Singapore, Taiwan and in the free trade agreement between the U.S. and the Central American countries. It also comments on the current state of negotiations on the Free Trade Agreement between the European Union and Canada. So the manual covers all important markets, which offer the possibility of a patent term extension. It is aimed at lawyers from pharmaceutical companies and international law firms. Its bilingual German/English synoptic structure is tailored to support the global development of innovative medicines. It facilitates the decision-making in international project teams through a rapid and easy access to all relevant information. It also assists to find uniform argumentation during grant or revocation proceedings across borders. The editor and the authors are acknowledged intellectual property law experts: Cheol-Gyoon Ahn, Senior Korean Patent Attorney, Seoul, Korea u Eran Bareket, Attorney at law, Tel-Aviv, Israel u Chen Ben Dori-Alkan, Attorney at Law, Tel-Aviv, Israel u Ronnie Benshafrut, Attorney at law, Tel-Aviv, Israel u Ruth Fang, Attorney at law, Taipei, Taiwan u Dr. Nicolai von Funer, Patent Attorney, Munich, Germany u Dr. Siegfried Grimm, Patent Attorney, Zurich, Switzerland u Brion P. Heaney, Patent Attorney, Arlington, USA u In-Hwan Kim, Senior Foreign Legal Counsel, Seoul, Korea u Peter Maddigan, Barrister, Sydney, Australia u Dr. Arne Markgraf, Attorney at law, Berlin, Germany u Dr. Olaf Meiselmann, Munich, Germany u Kristian Robinson, Patent Attorney, Singapore u Dr. Regula Ruedi, Patent Attorney, Zurich, Switzerland u Harry B. Shubin, Patent Attorney, Arlington, USA u Damian Slizys, Patent Attorney, Melbourne, Australia u Yoichi Watanabe, Patent Attorney, Tokyo, Japan u Paul Whenman, Patent Attorney, Sydney, Australia
